Home
Clinical Trials
The Dissemination of Consensu...

The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding

Last Updated: 2011-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

3157 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-09-30

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess whether adherence to NVUGIB guidelines is improved with implementation of a national, tailored multifaceted intervention. Outcomes include adherence rates to two key endoscopic and pharmacological therapy guidelines together (primary), or adherence to these individually as well as to other recommendations (secondary). Patient outcomes and economic data are also assessed (tertiary).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients

NCT01292915

Re-bleeding in NVUGIB

COMPLETED

Endoscopic Diagnosis and Treatment of Acute Nonvariceal Upper Gastrointestinal Bleeding

NCT04895904

Acute Upper Gastrointestinal Non Variceal Hemorrhage

COMPLETED

European Survey of Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB)

NCT00797641

Non-variceal Upper Gastrointestinal Bleeding Gastrointestinal Ulcer Gastrointestinal Hemorrhage

COMPLETED

Acute Lower gastroIntestinal BleedIng (ALIBI Study) in Italy

NCT04364412

Lower GI Bleeding

COMPLETED

Study of Patients With Drug-induced Non-variceal Upper Gastrointestinal Bleeding

NCT06945328

Upper Gastrointestinal Bleeding (UGIB)

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Clusters are randomized to receive a published algorithm and guidelines (control group), or a multifaceted, tailored educational intervention (see details in protocol - intervention group). The charts of treated patients with non variceal upper GI bleeding are reviewed and adherence to selected guidelines recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peptic Ulcer Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Educational intervention

see protocol

Group Type EXPERIMENTAL

Educational intervention

Intervention Type OTHER

As per detailed protocol.

Standard care

distribution of guidelines and a published algorithm

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Educational intervention

As per detailed protocol.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Multifacetted tailored educational intervention

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 or over.
* Treated during the study duration
* Primary or secondary discharge diagnoses of NVUGIB (per charted ICD-10 code). Additional confirmation of NVUGIB using endoscopic findings or patient symptoms done as previous.

Exclusion Criteria

* Patients initially assessed at another institution for the present episode of NVUGIB and subsequently transferred to the participating site with unavailable initial data.
* Endoscopy noted no gastro-duodenal ulcer bleeding, to ensure patient homogeneity.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers